AKTX
Akari Therapeutics
AKTX
AKTX
14 hedge funds and large institutions have $2.54M invested in Akari Therapeutics in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$71.3K | |
| 2 | +$58.2K | |
| 3 | +$29.7K | |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$20.1K |
| 5 |
Morgan Stanley
New York
|
+$8.9K |
Top Sellers
| 1 | -$2.61M | |
| 2 | -$59K | |
| 3 | -$46.3K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$41K |
| 5 |
Squarepoint
New York
|
-$41K |